Last reviewed · How we verify
Euphrasia Officinalis Preparation
Euphrasia officinalis (eyebright) is a herbal preparation that reduces ocular inflammation and irritation through its astringent and anti-inflammatory phytochemical constituents.
Euphrasia officinalis (eyebright) is a herbal preparation that reduces ocular inflammation and irritation through its astringent and anti-inflammatory phytochemical constituents. Used for Ocular irritation and inflammation, Conjunctivitis (mild to moderate).
At a glance
| Generic name | Euphrasia Officinalis Preparation |
|---|---|
| Sponsor | University of Bern |
| Drug class | Herbal preparation |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | Phase 3 |
Mechanism of action
The preparation contains flavonoids, tannins, and other polyphenolic compounds that exert anti-inflammatory and antioxidant effects on the ocular surface and conjunctival tissues. These constituents help reduce redness, tearing, and discomfort associated with eye irritation and mild inflammatory conditions of the eye.
Approved indications
- Ocular irritation and inflammation
- Conjunctivitis (mild to moderate)
Common side effects
- Local eye irritation
- Allergic reaction (rare)
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Euphrasia Officinalis Preparation CI brief — competitive landscape report
- Euphrasia Officinalis Preparation updates RSS · CI watch RSS
- University of Bern portfolio CI